clinical trials for tirzepatide Summary of that investigated weight loss using tirzepatide. Tirzepatide versus Semaglutide Once Weekly

Liraglutide (NN2211) is a long-acting GLP-1 receptor agonist used to treat type 2 diabetes and obesity (Victoza, Saxenda)

This infographic breaks down these drugs by active ingredients, brand names and approved uses of popular GLP-1s.

Explore the trend of celebrity body transformations net worth and how it reflects changing beauty standards in Hollywood.

Telehealth providers expanding into companion wellness products

Many patients notice their sugar cravings shift within weekssome fade completely, while others intensify temporarily

Compared with DPP-4 inhibitors, the lower rate of hyperkalemia was consistently observed across individual agents in the SGLT-2 inhibitor (canagliflozin, dapagliflozin, empagliflozin) and GLP-1 receptor agonist (dulaglutide, exenatide, liraglutide, semaglutide) classes